(Q34929018)

5 August 2017

1 reference

title

Cell cycle in sporadic melanoma (English)

1 reference

5 August 2017

Rafał Czajkowski

1

0 references

Tomasz Drewa

object named as

Tomasz Drewa

series ordinal

2

0 references

Alina Woźniak

series ordinal

3

object named as

Alina Woźniak

1 reference

5 August 2017

author name string

Ewa Krzyzyńska-Malinowska

series ordinal

4

1 reference

5 August 2017

publication date

1 September 2002

1 reference

International Journal of Dermatology

5 August 2017

published in

1 reference

5 August 2017

volume

41

1 reference

5 August 2017

issue

9

1 reference

5 August 2017

page(s)

550-556

1 reference

The pathogenesis of melanoma induced by ultraviolet radiation

5 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-4362.2002.01601.X

The risk of melanoma in association with long-term exposure to PUVA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-4362.2002.01601.X

Incidence of cancer among workers exposed to vinyl chloride in polyvinyl chloride manufacture

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-4362.2002.01601.X

A critical review of cancer epidemiology in the petroleum industry, with a meta-analysis of a combined database of more than 350,000 workers

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-4362.2002.01601.X

Melanoma genetics: an update with focus on the CDKN2A(p16)/ARF tumor suppressors

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-4362.2002.01601.X

Perspective: defects in cell cycle control and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-4362.2002.01601.X

The retinoblastoma protein pathway in cell cycle control and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-4362.2002.01601.X

CDK inhibitors: positive and negative regulators of G1-phase progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-4362.2002.01601.X

Introduction: p53--the first twenty years

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-4362.2002.01601.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-4362.2002.01601.X

Regulation of the p53 tumor suppressor protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-4362.2002.01601.X

The ubiquitin-proteasome pathway and pathogenesis of human diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-4362.2002.01601.X

Definition of the role of chromosome 9p21 in sporadic melanoma through genetic analysis of primary tumours and their metastases. The Melanoma Cooperative Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-4362.2002.01601.X

Molecular genetics of familial cutaneous melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-4362.2002.01601.X

Microsatellite instability and loss of heterozygosity in melanoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-4362.2002.01601.X

p16INK4a expression is frequently decreased and associated with 9p21 loss of heterozygosity in sporadic melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-4362.2002.01601.X

Loss of heterozygosity in human skin

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-4362.2002.01601.X

Expression of the tumor suppressor gene product p16INK4 in benign and malignant melanocytic lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-4362.2002.01601.X

Selective deletion of exon 1 beta of the p19ARF gene in metastatic melanoma cell lines.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-4362.2002.01601.X

Loss of p16Ink4a confers susceptibility to metastatic melanoma in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-4362.2002.01601.X

Loss of p16Ink4a with retention of p19Arf predisposes mice to tumorigenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-4362.2002.01601.X

p21(WAF1/CIP1) expression in stage I cutaneous malignant melanoma: its relationship with p53, cell proliferation and survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-4362.2002.01601.X

p16 and p21WAF1 protein expression in melanocytic tumors by immunohistochemistry

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-4362.2002.01601.X

Activation of a cAMP pathway and induction of melanogenesis correlate with association of p16(INK4) and p27(KIP1) to CDKs, loss of E2F-binding activity, and premature senescence of human melanocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-4362.2002.01601.X

Expression of p-27 (kip1) in nevi and melanomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-4362.2002.01601.X

Melanoma cell autonomous growth: the Rb/E2F pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-4362.2002.01601.X

Expression of cyclins and cyclin dependent kinases in human benign and malignant melanocytic lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-4362.2002.01601.X

Complete scanning of the CDK4 gene by denaturing gradient gel electrophoresis: a novel missense mutation but low overall frequency of mutations in sporadic metastatic malignant melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-4362.2002.01601.X

Deregulated E2F transcriptional activity in autonomously growing melanoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-4362.2002.01601.X

p53 mutations in human cutaneous melanoma correlate with sun exposure but are not always involved in melanomagenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-4362.2002.01601.X

Immune and gene therapy for melanoma, and the immunobiology of melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-4362.2002.01601.X

Isolation and characterisation of a novel human gene (C9orf11) on chromosome 9p21, a region frequently deleted in human cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-4362.2002.01601.X

Recent advances in melanoma research

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-4362.2002.01601.X

Timing of excessive ultraviolet radiation and melanoma: epidemiology does not support the existence of a critical period of high susceptibility to solar ultraviolet radiation- induced melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-4362.2002.01601.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-4362.2002.01601.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-4362.2002.01601.X

Genetic and environmental influences in the development of multiple primary melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-4362.2002.01601.X

p16INK4a inactivation is not frequent in uncultured sporadic primary cutaneous melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-4362.2002.01601.X

Loss of heterozygosity at chromosome 9p21 (INK4-p14ARF locus): homozygous deletions and mutations in the p16 and p14ARF genes in sporadic primary melanomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-4362.2002.01601.X

An analysis of p16 tumour suppressor gene expression in acral lentiginous melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-4362.2002.01601.X

p16INK4A and p19ARF act in overlapping pathways in cellular immortalization

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-4362.2002.01601.X

Overexpression of the cyclin-dependent kinase inhibitor p21(WAF1/CIP1) in human cutaneous malignant melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-4362.2002.01601.X

High levels of expression of p27KIP1 and cyclin E in invasive primary malignant melanomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-4362.2002.01601.X

Absence of p53 gene mutations in cutaneous melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-4362.2002.01601.X

Analysis of G1/S checkpoint regulators in metastatic melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-4362.2002.01601.X

Frequent mutations of the p53 gene in cutaneous melanoma of the nodular type

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-4362.2002.01601.X

New perspectives on immunobiology and immunotherapy of melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-4362.2002.01601.X

10.1046/J.1365-4362.2002.01601.X

21 January 2018

Identifiers

DOI

1 reference

5 August 2017

1 reference